University of Campania
Pediatrics
My current position is Assistant Professor of Pediatrics at the Department of Woman, Child and General and Specialized Surgery, University of Campania “Luigi Vanvitelli” and I am currently responsible of the Outpatient Clinic of Pediatric Gastroenterology. I became member of the ESPGHAN in 2009. I am currently part of the Young ESPGHAN Mentoring Program from 2017 and I am a member of the Research Committee and co-chair of the Special Interest Group on Basic and Translational Science from 2020. Moreover, I am an active member of the Open IBD Interest, Neurogastro, Motility and Functional Gastrointestinal Disorder Working Group and the Eosinophilic Gastrointestinal disorders Working group (EGIDs) Within the Special interest group, I took part in several multicenter studies and due to my activities, I was in the panel of the several consensus guidelines and position apper from the society. I am always been interested in pediatric gastroenterology and my many published scientific papers attest to my dedication towards clinical investigation in gastroenterology. I won several national and international awards and grants,among which the ESPGHAN Networking Grant 2018 with a project entitled: “ Diet and Functional gastrointestinal disorders in Mediterranean countries”, and with the same project also the John Harries Price 2021. I am currently principal investigator of 3 grants and one start up .

Moderator of 2 Sessions

Gastroenterology WG/SIG
Session Type
Gastroenterology WG/SIG
Date
Wed, 17.05.2023
Room
Hall -2.61
Session Time
11:30 - 13:00
Session Description
Medical scientific research has changed and progressed drastically over the past decade, alongside increasingly fast technological developments. This research symposium will provide attendees with the latest updates in clinical and scientific research methods and topics across PGHAN. Lectures will cover a broad range of highly relevant, current topics including wet lab technologies, organoids, high throughput data analysis, artificial intelligence, precision nutrition, and clinical trials. The symposium will end with a round table and a discussion with the audience about what ESPGHAN can offer to support high quality research and train his younger Members. A new ESPGHAN Research Curriculum will be presented and discussed.

Presenter of 3 Presentations

WHAT ARE THE FUTURE TRAJECTORIES IN PGHAN RESEARCH AND HOW CAN ESPGHAN SUPPORT YOUNGER MEMBERS IN CONDUCTING HIGH QUALITY RESEARCH? (ROUNDTABLE DISCUSSION) (ID 1697)

BRIEF INTRODUCTION ON THE REASONS BEHIND THE SYMPOSIUM I.E. THE CHANGING LANDSCAPE OF RESEARCH IN PGHAN AND ACROSS ESPGHAN (ID 1691)

Session Type
Gastroenterology
Date
Sat, 20.05.2023
Session Time
13:15 - 14:45
Room
Hall K
Lecture Time
13:15 - 13:20

G-O027 - ROLE OF MIRNA-21 AND MIRNA-223 IN CHILDREN WITH EOSINOPHILIC ESOPHAGITIS (ID 1008)

Session Type
Gastroenterology
Date
Sat, 20.05.2023
Session Time
13:15 - 14:45
Room
Hall C
Lecture Time
14:15 - 14:20

Abstract

Objectives and Study

Upper endoscopy with multiple biopsies is required for diagnosis and surveillance of eosinophilic esophagitis (EoE) to identify the maximal density of eosinophils. This procedure is invasive, time consuming, and expensive. There is a need for reliable non-invasive or minimally invasive biomarkers to avoid the significant burden on affected patients and the healthcare system. Recent studies have demonstrated the critical role of microRNA (miR) alterations in the development of chronic inflammatory processes as EoE. The aim of our study was to evaluate the role of miR21 and miR-223 in children with EoE.

Methods

We enrolled 10 children with EoE. Samples of plasma and esophagus from EoE patients were collected at diagnosis (T0), and after 8 weeks of therapy with PPI or topical corticosteroid (T1) and compared with respective control samples. After miRNAs extraction, the level of miR-21 and miR-223 and their relevant target genes were analysed by real time PCR.

Results

Serum and esophageal expression of miR-21 and miR-223 resulted significantly higher in patients with EoE than in CTR at T0 (p<0.005). The upregulation in plasma mirrors what happens in tissue but is easier to follow. MiR-21 and miR-223 trends decline when patients are in remission. Indeed, we found a significant reduction of serum miR-21 and miR-223 at T1. By bioinformatic analysis we identified target genes of our miRNAs and the most significant pathways in which these genes are involved. We found relevant pathways such as Foxo, TGFb and AGE-RAGE signalling pathways and abnormal levels of relevant target genes, such as PTEN, AKT, TGFb1 and STAT3, involved in inflammatory processes, which can be affected by increased level of miR-21 and miR-223.

Conclusions

Our preliminary results suggest that the miR-21 and miR-223 expressions could be useful as markers of esophageal inflammation at diagnosis and during follow up in EoE children.

Hide